08 Nov
|
Wwshemi
|
Sydney
Iovance Biotherapeutics seeks a senior commercial leader based in Australia to own the Australian AMTAGVI and Proleukin commercialisation.
You will drive the launch plan, oversee P&L;, and build long-range commercial strategies across treatment centres, referral networks and health authorities.You will manage end-to-end sales, forecast demand, and coordinate cross-functional teams, ensuring compliant execution and patient access to creative TIL therapies in Australia.
#J-*****-Ljbffr
📌 Australia Commercial Lead — Til Therapy Launch (Sydney)
🏢 Wwshemi
📍 Sydney